Encompass Health Co. (NYSE:EHC) Shares Acquired by Franklin Resources Inc.

Franklin Resources Inc. increased its holdings in shares of Encompass Health Co. (NYSE:EHC) by 22.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 700,021 shares of the company’s stock after acquiring an additional 126,000 shares during the period. Franklin Resources Inc. owned approximately 0.69% of Encompass Health worth $67,412,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of EHC. Point72 Asset Management L.P. increased its stake in Encompass Health by 2,458.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after purchasing an additional 835,135 shares in the last quarter. Magnetar Financial LLC increased its position in shares of Encompass Health by 1,176.6% in the second quarter. Magnetar Financial LLC now owns 744,836 shares of the company’s stock valued at $63,899,000 after buying an additional 814,018 shares in the last quarter. Thrivent Financial for Lutherans raised its stake in shares of Encompass Health by 2,302.7% during the 2nd quarter. Thrivent Financial for Lutherans now owns 603,558 shares of the company’s stock worth $51,780,000 after buying an additional 578,438 shares during the last quarter. AQR Capital Management LLC boosted its position in shares of Encompass Health by 213.3% in the 2nd quarter. AQR Capital Management LLC now owns 207,202 shares of the company’s stock worth $17,776,000 after buying an additional 141,075 shares in the last quarter. Finally, Cubist Systematic Strategies LLC grew its stake in Encompass Health by 762.4% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 83,347 shares of the company’s stock valued at $7,150,000 after acquiring an additional 73,683 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analysts Set New Price Targets

EHC has been the topic of several recent research reports. Barclays upped their price target on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Royal Bank of Canada increased their target price on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Truist Financial reissued a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. KeyCorp increased their price objective on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Finally, UBS Group boosted their target price on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, September 25th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Encompass Health has an average rating of “Buy” and an average price target of $107.11.

Encompass Health Stock Down 0.5 %

EHC opened at $97.70 on Tuesday. Encompass Health Co. has a 12 month low of $65.39 and a 12 month high of $104.55. The business has a 50-day moving average of $99.42 and a two-hundred day moving average of $92.70. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a market capitalization of $9.84 billion, a price-to-earnings ratio of 23.60, a price-to-earnings-growth ratio of 1.34 and a beta of 0.86.

Encompass Health (NYSE:EHC) last released its earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. Encompass Health’s revenue was up 11.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.86 earnings per share. On average, research analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.